Back to User profile » Dr Zhang Hongyan
Papers published by Dr Zhang Hongyan:
Safety and efficacy of paliperidone extended-release in Chinese patients with schizophrenia: a 24-week, open-label extension of a randomized, double-blind, placebo-controlled study
Zhang H, Li H, Liu Y, Wu C, Wu Q, Nuamah I, Shi J, Xie S, Wang G, Gopal S
Neuropsychiatric Disease and Treatment 2016, 12:69-77
Published Date: 8 January 2016
Efficacy and safety of an oral contraceptive containing ethinylestradiol 20 µg/drospirenone 3 mg (24/4 regimen) in three indications in the People's Republic of China: a comparison with international studies
Marr J, Huang Z, Wang B, Zhang H, Roth K
Open Access Journal of Contraception 2015, 6:95-104
Published Date: 10 July 2015
Psychiatrists' awareness of partial and nonadherence to antipsychotic medication in schizophrenia: results from an Asia–Pacific survey
Olivares JM, Thirunavukarasu M, Kulkarni J, Zang HY, Zhang M, Zhang F
Neuropsychiatric Disease and Treatment 2013, 9:1163-1170
Published Date: 12 August 2013
Double-blind comparison of ziprasidone and risperidone in the treatment of Chinese patients with acute exacerbation of schizophrenia
Hongyan Zhang, Huafang Li, Liang Shu, et al
Neuropsychiatric Disease and Treatment 2011, 7:77-85
Published Date: 4 March 2011